UK markets open in 3 hours
NIKKEI 225
38,755.50 +519.43 (+1.36%) HANG SENG
18,429.14 -149.16 (-0.80%) CRUDE OIL
78.72 +0.24 (+0.31%) GOLD FUTURES
2,331.70 +0.50 (+0.02%) DOW
38,852.27 +176.59 (+0.46%) Bitcoin GBP
50,361.64 -514.98 (-1.01%)
Boston Scientific Corporation (BSX)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 72.85 |
| Open | 73.04 |
| Bid | 72.30 x 1200 |
| Ask | 73.60 x 1000 |
| Day's range | 72.42 - 73.27 |
| 52-week range | 48.35 - 74.39 |
| Volume | |
| Avg. volume | 6,410,320 |
| Market cap | 107.103B |
| Beta (5Y monthly) | 0.79 |
| PE ratio (TTM) | 61.48 |
| EPS (TTM) | 1.18 |
| Earnings date | 25 Jul 2024 - 29 Jul 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 81.86 |
ZacksA Golden Opportunity to Enter U.S. Stock Markets: 5 Top Picks
We have narrowed our search to five U.S. corporate behemoths that have strong growth potential for 2024. These are: GOOGL, NFLX, AMZN, NOW, BSX.
ZacksAvanos (AVNS) Q1 Earnings & Revenues Surpass Estimates
Avanos' (AVNS) first-quarter results show strong bottom-line improvement along with decent growth in segmental revenues.
ZacksSurmodics (SRDX) Q2 Earnings Top Estimates, '24 View Up
Surmodics (SRDX) fiscal second-quarter results showcase growth in the medical device segment. The bottom line improves and beats the Zacks Consensus Estimate.
© 2024 Yahoo. All rights reserved.